DE LAURENTIIS, MICHELINO
DE LAURENTIIS, MICHELINO
DIPARTIMENTO DI MEDICINA CLINICA E CHIRURGIA
Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part
2007 G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino
Targeted Therapy of Breast Cancer
2009 DE LAURENTIIS, Michelino; Zielinski, C.
Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up.
1999 DE PLACIDO, Sabino; Carlomagno, Chiara; Ciardiello, F; DE LAURENTIIS, Michelino; Pepe, Stefano; Ruggiero, A; Tortora, Giampaolo; Panico, L; D’ ANTONIO, A; Pettinato, Guido; Petrella, Giuseppe; Bianco, Ar
Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A.
2000 Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo
A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer.
2005 DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Manuale di Oncologia Clinica
1996 Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo
Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease.
2003 DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino
High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer.
2014 Criscitiello, C; Disalvatore, D; DE LAURENTIIS, Michelino; Gelao, L; Fumagalli, L; Locatelli, M; Bagnardi, V; Rotmensz, N; Esposito, A; Minchella, I; DE PLACIDO, Sabino; Santangelo, Michele; Viale, G; Goldhirsch, A; Curigliano, G.
The prognostic value of lymphatic and blood vessel invasion in operable breast cancer.
1995 Lauria, R.; Perrone, F.; Carlomagno, Chiara; DE LAURENTIIS, Michelino; Morabito, A.; Gallo, C.; Varriale, E.; Pettinato, Guido; Panico, L.; Petrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER.
2002 DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F.
Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination.
1995 P., Tagliaferri; Matano, Elide; A., Rea; M., Famiani; F., Ciardiello; G., Tortora; V., Montesarchio; A., Morabito; M., Caraglia; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Palmieri, Giovannella; A. R., Bianco
Survival Analysis by means of a novel Neural Network Model
2003 Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino
Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study.
2007 DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino
Survival analysis of censored data: neural network analysis detection of complex interactions between variables.
1994 DE LAURENTIIS, Michelino; P. M., Ravdin
Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer.
1993 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer.
1993 A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo
HER-2/neu receptor in prostate cancer development and progression to androgen independence.
2004 Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Luca, Cindolo; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes?
1996 F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino
Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study.
1994 F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE
Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial.
2007 Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Valeria, Forestieri; Carmela, Romano; Antonella, Prudente; Francesco, Giugliano; Ciro, Imbimbo; Vincenzo, Mirone; DE PLACIDO, Sabino
| Titolo | Tipologia | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|---|
| Phase I-II study of xelox and bevacizumab plus erlotinib in sequential combination (XELOX-TARAV) in first line colorectal cancer: run in part | 1.5 Abstract in rivista | 2007 | G., Tortora; Carlomagno, Chiara; Bianco, Roberto; Daniele, G; Pepe, S; Leopardo, D; Marciano, Roberta; DE LAURENTIIS, Michelino; F., Ciardiello; DE PLACIDO, Sabino | |
| Targeted Therapy of Breast Cancer | 8.01 Chairman di Sessioni di Convegni Internazionali | 2009 | DE LAURENTIIS, Michelino; Zielinski, C. | |
| Measurement of neovascularization is an independent prognosticator of survival in node-negative breast cancer patients with long-lerm follow-up. | 1.1 Articolo in rivista | 1999 | DE PLACIDO, Sabino; Carlomagno, Chiara; Ciardiello, F; DE LAURENTIIS, Michelino; Pepe, Stefano; Ruggiero, A; Tortora, Giampaolo; Panico, L; D’ ANTONIO, A; Pettinato, Guido; Petrella, Giuseppe; Bianco, Ar | |
| Resistance to taxanes is induced by c-erbB-2 overexpression in human MCF-10A mammary epithelial cells and is blocked by combined treatment with an antisense oligonucleotide targeting protein kinase A. | 1.1 Articolo in rivista | 2000 | Ciardiello, F; Caputo, R; Pomatico, G; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Bianco, Ar; Tortora, Giampaolo | |
| A meta-analysis on the interaction between HER-2 expression and response to endocrine treatment in advanced breast cancer. | 1.1 Articolo in rivista | 2005 | DE LAURENTIIS, Michelino; Arpino, Grazia; Massarelli, E; Ruggiero, A; Carlomagno, C; Ciardiello, F; Tortora, Giampaolo; D'Agostino, D; Caputo, F; Cancello, G; Montagna, E; Malorni, L; Zinno, L; Lauria, Rossella; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Manuale di Oncologia Clinica | 2.1 Contributo in volume (Capitolo o Saggio) | 1996 | Bianco, ANGELO RAFFAELE; E., Biondi; Carlomagno, Chiara; Ciardiello, Fortunato; Contegiacomo, Alma; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Lauria, Rossella; Marinelli, Alfredo; Matano, Elide; A., Morabito; Palmieri, Giovannella; Pepe, Stefano; F., Perrone; P., Tagliaferri; Tortora, Giampaolo | |
| Is there a standard chemotherapeutic regimen for hormone-refractory prostate cancer? Present and future approaches in the management of the disease. | 1.1 Articolo in rivista | 2003 | DI LORENZO, Giuseppe; Autorino, Riccardo; DE LAURENTIIS, Michelino; Bianco, Roberto; Lauria, Rossella; Giordano, A; De Sio, M; D'Armiento, Massimino; Bianco, Ar; DE PLACIDO, Sabino | |
| High Ki-67 score is indicative of a greater benefit from adjuvant chemotherapy when added to endocrine therapy in Luminal B HER2 negative and node-positive breast cancer. | 1.1 Articolo in rivista | 2014 | Criscitiello, C; Disalvatore, D; DE LAURENTIIS, Michelino; Gelao, L; Fumagalli, L; Locatelli, M; Bagnardi, V; Rotmensz, N; Esposito, A; Minchella, I; DE PLACIDO, Sabino; Santangelo, Michele; Viale, G; Goldhirsch, A; Curigliano, G. | |
| The prognostic value of lymphatic and blood vessel invasion in operable breast cancer. | 1.1 Articolo in rivista | 1995 | Lauria, R.; Perrone, F.; Carlomagno, Chiara; DE LAURENTIIS, Michelino; Morabito, A.; Gallo, C.; Varriale, E.; Pettinato, Guido; Panico, L.; Petrella, G.; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| EXPRESSION OF EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) CORRELATES WITH DISEASE RELAPSE AND PROGRESSION TO ANDROGEN-INDEPEDENCE IN HUMAN PROSTATE CANCER. | 1.1 Articolo in rivista | 2002 | DI LORENZO, G; Tortora, G; D'Armiento, FRANCESCO PAOLO; DE ROSA, G; Staibano, Stefania; Autorino, R; D'Armiento, Maria; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Catalano, G; Bianco, Ar; Ciardiello, F. | |
| Mitoxantrone, etoposide and bleomycin (MEB) chemotherapy in non-Hodgkin's Lymphoma patients non-elegible for standard cyclophosphamide, doxorubicin vincristine and prednisone (CHOP) combination. | 1.1 Articolo in rivista | 1995 | P., Tagliaferri; Matano, Elide; A., Rea; M., Famiani; F., Ciardiello; G., Tortora; V., Montesarchio; A., Morabito; M., Caraglia; DE LAURENTIIS, Michelino; DE PLACIDO, Sabino; Palmieri, Giovannella; A. R., Bianco | |
| Survival Analysis by means of a novel Neural Network Model | 1.1 Articolo in rivista | 2003 | Eleuteri, A; Tagliaferri, R; DE PLACIDO, Sabino; DE LAURENTIIS, Michelino | |
| Docetaxel, vinorelbine, and zoledronic acid as first-line treatment in patients with hormone refractory prostate cancer: a phase II study. | 1.1 Articolo in rivista | 2007 | DI LORENZO, G; Autorino, R; Perdona, S; DE LAURENTIIS, Michelino; D'Armiento, FRANCESCO PAOLO; Cancello, G; Mirone, Vincenzo; Imbimbo, Ciro; Longo, Nicola; Altieri, Vincenzo; Tortora, Giampaolo; Figg, Wd; DE PLACIDO, Sabino | |
| Survival analysis of censored data: neural network analysis detection of complex interactions between variables. | 1.1 Articolo in rivista | 1994 | DE LAURENTIIS, Michelino; P. M., Ravdin | |
| Chemotherapy with mitomycin C and vinblastine in pretreated metastatic breast cancer. | 1.1 Articolo in rivista | 1993 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; F., Nuzzo; A., Ruggiero; DE LAURENTIIS, Michelino; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
| Endocrine factors in the outcome of systemic adjuvant therapy of early breast cancer. | 1.1 Articolo in rivista | 1993 | A. R., Bianco; DE PLACIDO, Sabino; F., Perrone; Carlomagno, Chiara; DE LAURENTIIS, Michelino; L., Del Mastro; R., Lauria; Marinelli, Alfredo; C., Gallo | |
| HER-2/neu receptor in prostate cancer development and progression to androgen independence. | 1.1 Articolo in rivista | 2004 | Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Luca, Cindolo; Massimo, D'Armiento; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Selecting high-risk early breast cancer patients: what to add to the number of metastatic nodes? | 1.1 Articolo in rivista | 1996 | F., Perrone; Carlomagno, Chiara; R., Lauria; DE LAURENTIIS, Michelino; A., Morabito; L., Panico; Pettinato, Guido; G., Petrella; C., Gallo; Bianco, ANGELO RAFFAELE; DE PLACIDO, Sabino | |
| Mitomycin C and mitoxantrone in anthracycline-pretreated advanced breast cancer patients. A phase II study. | 1.1 Articolo in rivista | 1994 | F., Perrone; DE PLACIDO, Sabino; Carlomagno, Chiara; A., Gravina; DE LAURENTIIS, Michelino; L., Del Mastro; C., Gridelli; Pagliarulo, Clorindo; Bianco, ANGELO RAFFAELE | |
| Thalidomide in combination with oral daily cyclophosphamide in patients with pretreated hormone refractory prostate cancer: a phase I clinical trial. | 1.1 Articolo in rivista | 2007 | Giuseppe Di, Lorenzo; Riccardo, Autorino; DE LAURENTIIS, Michelino; Valeria, Forestieri; Carmela, Romano; Antonella, Prudente; Francesco, Giugliano; Ciro, Imbimbo; Vincenzo, Mirone; DE PLACIDO, Sabino |